Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Astrotech Co. stock logo
ASTC
Astrotech
$5.50
-1.8%
$5.85
$5.39
$12.29
$9.32M0.2514,744 shs4,791 shs
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
$0.65
$0.03
$2.09
$857K0.22505,607 shs53.64 million shs
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
$0.51
+0.1%
$0.40
$0.28
$3.60
$22.51M1.563.09 million shs1.21 million shs
Cue Health Inc. stock logo
HLTH
Cue Health
$0.04
-29.8%
$0.07
$0.04
$0.74
$6.91M1.0913.38 million shs96.00 million shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Astrotech Co. stock logo
ASTC
Astrotech
-3.34%-4.35%-6.14%-13.66%-41.43%
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
0.00%0.00%0.00%-96.42%-97.00%
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
+0.08%-8.79%+49.94%-24.42%-82.41%
Cue Health Inc. stock logo
HLTH
Cue Health
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Astrotech Co. stock logo
ASTC
Astrotech
0.5656 of 5 stars
0.03.00.00.01.90.80.6
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
0.9136 of 5 stars
0.00.00.04.70.02.50.6
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
3.884 of 5 stars
3.32.00.04.52.11.70.6
Cue Health Inc. stock logo
HLTH
Cue Health
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Astrotech Co. stock logo
ASTC
Astrotech
0.00
N/AN/AN/A
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
4.00
Strong BuyN/AN/A
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
2.50
Moderate Buy$3.00489.16% Upside
Cue Health Inc. stock logo
HLTH
Cue Health
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest HLTH, HBIO, AXDX, and ASTC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/13/2025
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSpeculative Buy ➝ Speculative Buy$4.50 ➝ $3.00
4/9/2025
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Sector Weight
3/24/2025
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSpeculative Buy ➝ Speculative Buy$5.50 ➝ $4.50
(Data available from 6/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Astrotech Co. stock logo
ASTC
Astrotech
$903K10.32N/AN/A$20.45 per share0.27
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
$11.70M0.00N/AN/A($1.37) per share0.00
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
$91.40M0.25$0.10 per share5.16$1.71 per share0.30
Cue Health Inc. stock logo
HLTH
Cue Health
$70.94M0.10N/AN/A$1.62 per share0.03
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Astrotech Co. stock logo
ASTC
Astrotech
-$11.67M-$8.42N/AN/A-3,198.09%-40.44%-37.41%N/A
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
-$61.62M-$2.34N/AN/AN/A-471.83%N/A-191.66%N/A
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
-$3.41M-$1.32N/AN/A-14.57%-4.64%-2.40%8/6/2025 (Estimated)
Cue Health Inc. stock logo
HLTH
Cue Health
-$373.46M-$2.44N/AN/AN/A-526.48%-67.82%-53.79%N/A

Latest HLTH, HBIO, AXDX, and ASTC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2025Q3 2025
Astrotech Co. stock logo
ASTC
Astrotech
N/A-$2.18N/A-$2.18N/AN/A
3/20/2025Q4 2024
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
-$0.50-$0.37+$0.13-$0.37$3.00 million$2.82 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Astrotech Co. stock logo
ASTC
Astrotech
N/AN/AN/AN/AN/A
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
N/AN/AN/AN/AN/A
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
N/AN/AN/AN/AN/A
Cue Health Inc. stock logo
HLTH
Cue Health
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Astrotech Co. stock logo
ASTC
Astrotech
N/A
10.74
9.73
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
N/A
1.50
1.34
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
0.52
2.06
0.91
Cue Health Inc. stock logo
HLTH
Cue Health
N/A
2.54
2.22

Institutional Ownership

CompanyInstitutional Ownership
Astrotech Co. stock logo
ASTC
Astrotech
24.35%
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
17.14%
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
80.87%
Cue Health Inc. stock logo
HLTH
Cue Health
45.49%

Insider Ownership

CompanyInsider Ownership
Astrotech Co. stock logo
ASTC
Astrotech
14.90%
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
43.60%
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
9.50%
Cue Health Inc. stock logo
HLTH
Cue Health
12.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Astrotech Co. stock logo
ASTC
Astrotech
101.69 million1.45 millionNot Optionable
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
22025.21 million14.13 millionOptionable
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
49044.21 million39.69 millionOptionable
Cue Health Inc. stock logo
HLTH
Cue Health
726159.09 million139.21 millionOptionable

Recent News About These Companies

Three Trends Coming out of HLTH So Far
Where health systems are heading with AI
Trends to watch at HLTH 2024
New Counterpart CMO talks Clover Health's AI capabilities
FDA revokes EUA for Cue Health COVID-19 tests
HLTH 2024: A Bold Step into the Future of Food as Medicine
Cue Tips: Hold your cue stick loosely

New MarketBeat Followers Over Time

Media Sentiment Over Time

Astrotech stock logo

Astrotech NASDAQ:ASTC

$5.50 -0.10 (-1.79%)
Closing price 06/16/2025 04:00 PM Eastern
Extended Trading
$5.38 -0.13 (-2.27%)
As of 06/16/2025 05:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Astrotech Corporation operates as a mass spectrometry company worldwide. It owns and licenses the intellectual property related to the Astrotech Mass Spectrometer Technology, a platform mass spectrometry technology. The company also develops TRACER 1000, a mass spectrometer-based explosive trace detector to replace the explosives trace detectors used at airports, cargo and other secured facilities, and borders. In addition, it develops AgLAB-1000, a mass spectrometer for use in the hemp and cannabis market. Further, the company develops BreathTest-1000, a breath analysis tool to screen for volatile organic compound metabolites found in a person's breath. The company was formerly known as SPACEHAB, Inc. and changed its name to Astrotech Corporation in 2009. The company was incorporated in 1984 and is based in Austin, Texas.

Accelerate Diagnostics stock logo

Accelerate Diagnostics NASDAQ:AXDX

$0.04 +0.04 (+∞)
As of 05/14/2025
This is a fair market value price provided by Polygon.io. Learn more.

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.

Harvard Bioscience stock logo

Harvard Bioscience NASDAQ:HBIO

$0.51 +0.00 (+0.08%)
Closing price 06/16/2025 04:00 PM Eastern
Extended Trading
$0.51 +0.00 (+0.16%)
As of 04:52 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It also provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through sales organizations, websites, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic labs. It primarily sells its products under Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.

Cue Health stock logo

Cue Health NASDAQ:HLTH

Cue Health Inc. operates as a healthcare technology company. It provides the Cue Health platform that offers individuals and healthcare providers convenient and personalized access to lab-quality diagnostic tests at home and at the point-of-care, as well as on-demand telehealth consultations and treatment options for a range of health and wellness needs. It offers Cue Integrated Care platform comprising hardware, software, and diagnostic components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, including integration with electronic medical record system, pharmacies and last-mile delivery, clinician networks, and laboratories. The company also provides COVID-19 testing kits. The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.